ReferenceID 6552
Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling
J Ethnopharmacol
ETHNOPHARMACOLOGICAL RELEVANCE: Shensong Yangxin Capsule (SSYX), a traditional Chinese herbal medicine, has long been used clinically to treat arrhythmias in China. However, the effect of SSYX on interstitial fibrosis in
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 6552
- Evidence Id
- 23142
- Core Evidence Id
- 23142
- Source Reference Id
- 6409
- Herb2 Reference Id
- HBREF007206
- Subject Paper Key
- HBFO000697_25267579
- Pubmed Id
- 25267579
- Doi
- 10.1016/j.jep.2014.09.035
- Paper Title
- Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling
- Paper Abstract
- ETHNOPHARMACOLOGICAL RELEVANCE: Shensong Yangxin Capsule (SSYX), a traditional Chinese herbal medicine, has long been used clinically to treat arrhythmias in China. However, the effect of SSYX on interstitial fibrosis in diabetic cardiomyopathy is unknown. The objective of this study was to investigate the effects of SSYX on myocardial fibrosis in diabetic rats. MATERIALS AND METHODS: The antifibrotic effect of SSYX was investigated in streptozocin (STZ)-induced diabetic rats with high fat-diet (HFD). Fasting blood glucose, heart weight/body weight (HW/BW) ratio, total cholesterol (TC), triglycerides (TG), high density lipoprotein (HDL) and low density lipoprotein (LDL) were measured. Echocardiography and histology examination were carried out to evaluate heart function. Expressions of Smad7, TGF-beta1, collagen I (col-1), collagen III (col-3), MMP-2, MMP-9 and alpha-SMA mRNA in heart tissues were measured by real time polymerase chain reaction (PCR). TGF-beta1, Smad2/3, p-Smad2/3 and Smad7 protein levels were measured by western blot analysis. Proliferation of cardiac fibroblast was detected via immunofluorescence. RESULTS: SSYX markedly decreased HW/BW ratio and improved the impaired cardiac function of type-2 diabetes mellitus (T2DM) rats. Transmission electron microscopy (TEM), haematoxylin and eosin (HE) and Masson staining results showed that SSYX attenuated cardiac fibrosis and collagen deposition in T2DM rats. Moreover, mRNA levels of TGF-beta1, col-1, col-3, MMP-2, MMP-9 and alpha-SMA were downregulated, whereas Smad7 expression was upregulated after treatment with SSYX in rats with cardiac fibrosis. Furthermore, SSYX decreased protein levels of TGF-beta1 and p-Smad2/3, and increased Smad7 expression. CONCLUSION: TGF-beta1/Smad signaling is involved in the cardiac fibrosis in diabetic cardiomyopathy and SSYX inhibits fibrosis and improves cardiac function via suppressing this pathway. Therefore, SSYX might be considered as an alternative therapeutic remedy for diabetic cardiomyopathy.
- Journal
- J Ethnopharmacol
- Publish Year
- 2014
- Experiment Subject
- rat
- Experiment Type
- Animal Experiment
- Phenotype Related
- Type-2 Diabetes Mellitus; Interstitial Fibrosis; Fibrosis; Arrhythmias; Myocardial Fibrosis; Cardiac Fibrosis; Diabetic Cardiomyopathy; Diabetic
- Paper Title Cn
- Paper Title En
- Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling
- Bilingual Status
- semi_complete